DE3483881D1 - 1,3-dioxan-4-ylalkensaeure. - Google Patents

1,3-dioxan-4-ylalkensaeure.

Info

Publication number
DE3483881D1
DE3483881D1 DE8484307658T DE3483881T DE3483881D1 DE 3483881 D1 DE3483881 D1 DE 3483881D1 DE 8484307658 T DE8484307658 T DE 8484307658T DE 3483881 T DE3483881 T DE 3483881T DE 3483881 D1 DE3483881 D1 DE 3483881D1
Authority
DE
Germany
Prior art keywords
formula
alkyl
sub
compounds
dioxane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8484307658T
Other languages
English (en)
Inventor
Brian Geoffrey Main
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Application granted granted Critical
Publication of DE3483881D1 publication Critical patent/DE3483881D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/081,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/28Alcohols containing only six-membered aromatic rings as cyclic part with unsaturation outside the aromatic rings
    • C07C33/30Alcohols containing only six-membered aromatic rings as cyclic part with unsaturation outside the aromatic rings monocyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/42Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/48Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Fats And Perfumes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Lubricants (AREA)
  • Steroid Compounds (AREA)
  • Liquid Crystal Substances (AREA)
DE8484307658T 1983-11-11 1984-11-06 1,3-dioxan-4-ylalkensaeure. Expired - Fee Related DE3483881D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838330097A GB8330097D0 (en) 1983-11-11 1983-11-11 Cyclic ethers

Publications (1)

Publication Number Publication Date
DE3483881D1 true DE3483881D1 (de) 1991-02-07

Family

ID=10551594

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484307658T Expired - Fee Related DE3483881D1 (de) 1983-11-11 1984-11-06 1,3-dioxan-4-ylalkensaeure.

Country Status (15)

Country Link
US (1) US4704399A (de)
EP (1) EP0145260B1 (de)
JP (1) JPS60136580A (de)
AT (1) ATE59387T1 (de)
AU (1) AU576530B2 (de)
CA (1) CA1259323A (de)
DE (1) DE3483881D1 (de)
DK (1) DK535384A (de)
ES (1) ES8606326A1 (de)
GB (1) GB8330097D0 (de)
GR (1) GR80832B (de)
IL (1) IL73372A (de)
NZ (1) NZ210158A (de)
PT (1) PT79478B (de)
ZA (1) ZA848304B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8330094D0 (en) * 1983-11-11 1983-12-21 Ici Plc Diphenyl compounds
GB8511891D0 (en) * 1985-05-10 1985-06-19 Ici Plc Alkenoic acids
DE3685775T2 (de) * 1985-05-10 1993-01-21 Ici Plc Alkenderivate.
HU198706B (en) * 1985-05-10 1989-11-28 Ici Plc Process for producing 1,3-dioxan-ethers and pharmaceutical compositions containing them
GB8611174D0 (en) * 1986-05-08 1986-06-18 Ici Plc Amide derivatives
ATE56967T1 (de) * 1985-11-12 1990-10-15 Ici Plc Amidderivate.
US5248780A (en) * 1988-02-16 1993-09-28 Imperial Chemical Industries, Plc Pyridyl substituted alkenoic acid derivatives
GB9021571D0 (en) * 1990-10-04 1990-11-21 Ici Plc Heterocyclic acids

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2992234A (en) * 1959-06-16 1961-07-11 Du Pont 6, 8-(methylenedioxy)-2, 4-octadienoic acid and its alkyl esters
SU550391A1 (ru) * 1975-06-04 1977-03-15 Уфимский Нефтяной Институт 1,3-Диоксанкарбоновые кислоты в качестве пластификаторов поливинилхлорида
GB8310407D0 (en) * 1982-05-12 1983-05-25 Ici Plc 1 3 - dioxan -5- ylalkenoic acids
GB8330094D0 (en) * 1983-11-11 1983-12-21 Ici Plc Diphenyl compounds

Also Published As

Publication number Publication date
PT79478B (en) 1987-01-13
DK535384A (da) 1985-05-12
EP0145260A2 (de) 1985-06-19
ES8606326A1 (es) 1986-04-16
ZA848304B (en) 1985-06-26
CA1259323A (en) 1989-09-12
ATE59387T1 (de) 1991-01-15
JPS60136580A (ja) 1985-07-20
PT79478A (en) 1984-12-01
NZ210158A (en) 1988-04-29
IL73372A (en) 1988-05-31
AU576530B2 (en) 1988-09-01
US4704399A (en) 1987-11-03
AU3495584A (en) 1985-05-16
IL73372A0 (en) 1985-01-31
DK535384D0 (da) 1984-11-09
ES537541A0 (es) 1986-04-16
EP0145260B1 (de) 1990-12-27
EP0145260A3 (en) 1986-02-26
GB8330097D0 (en) 1983-12-21
GR80832B (en) 1984-12-13

Similar Documents

Publication Publication Date Title
AU7137591A (en) New derivatives having naphthalene structure, process for preparing these and pharmaceutical compositions containing them
IE45256L (en) Quinazolone derivatives
ES483767A1 (es) Procedimiento para producir n-arilsulfonil-l-argininamidas
US4122105A (en) Cis-4,5-didehydro-12,13(E)didehydro-13,14-dihydro-PGD1 compounds
ATE59387T1 (de) 1,3-dioxan-4-ylalkensaeure.
ATE19773T1 (de) Nitroaliphatische verbindungen, verfahren zu deren herstellung und deren verwendung.
ES537542A0 (es) Procedimiento para la obtencion de derivados de ciclohexano.
DE3267188D1 (en) Hydroxybenzylamino-aryl compounds, process for preparing and pharmaceutical compositions containing the same
ES8101646A1 (es) Un procedimiento para producir un compuesto opticamente ac- tivo
HUT53103A (en) Process for the preparation of new 20,21-dinor-eburnamenine derivatives, new intermediates thereof, as well as pharmaceutical compositions containing said compounds as active ingredients
DE3372773D1 (de) 7-oxo-4-thia-1-azabicyclo(3,2,0)heptane derivatives
IE39543B1 (en) Novel cephalosporanic derivatives process for their preparation and compositions incorporating them
JPS5531086A (en) Prepartion of 5,6-epoxy-1,2,6-trimethyl-tricyclo 5.3.2.02,7 dodecane
ES8105713A1 (es) Un procedimiento para la preparacion de los enatiomeros levogiro y dextrogiro de la 1-ciclopropil-metil-4-(3-metoxi-5h- dibenzo (a,d) ciclohepten-5-iliden) piperidina

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee